A quick reaction clip from obesity medicine doctor Spencer Nadolsky responding to a joke about GLP-1 drugs. Light content with no new information.
Recap by typeshit. Post by @drnadolsky on Instagram.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
Novo also presented liver fat data from STEP-UP and an Ozempic vs Mounjaro heart risk analysis, and paid $300 million upfront for Hengrui's HRS-1596.
19:56
A performance coach shares his own checklist for people beginning retatrutide, the Lilly drug that is still in trials and not approved.
Loading…